Print
Technology

PPD Portion Of Thermo Fisher Forms Partnership With AI Company

By Johanna Cano, posted Feb 7, 2022
Thermo Fisher Scientific has formed a partnership between PPD clinical research and an artificial intelligence company to support clinical trials with big data and analytics.

According to a press release Monday, the multi-year partnership involves Medidata Acorn AI, a company specializing in pharmacy, specialty distributor and patient services data.

This partnership comes a few months after the completion of Thermo Fisher’s purchase of Wilmington-based PPD last year.

Through this collaboration, PPD and Medidata have formed PPD TrueCast, an application combining extensive patient recruitment and site performance data with predictive models and advanced analytics, the release stated.

The goal of the partnership is to optimize clinical research site selection and speed of patient enrollment in clinical trials.

“Offering one of the industry’s most wide-ranging representations of real-time site performance combined with machine learning, this new platform gives pharmaceutical and biotech companies actionable insights to optimize clinical research site selection, trial enrollment and study cycle times,” the release stated.

PPD TrueCast is a response to the continued growth of the clinical trial industry, David M, Johnston, senior vice president and president of clinical research at Thermo Fisher Scientific, said in the release.

“The clinical trial industry continues to demand new tools in big data and predictive analytics to improve trial planning and execution and accelerate clinical trials," Johnston said.

TrueCast, providing real-time data from global trial sites, uses artificial intelligence to forecast cycle times and enrollment performance.

According to the release, this includes data from Thermo Fisher’s clinical research business from 40,000 sites, 50,000 investigators and more than 2,000 studies. In addition, Medidata’s datasets include more than 26,000 clinical trials and nearly 8 million patients in more than 140 countries.

“... the average Phase III study enrollment period was reduced by an average of 1.5 months in retrospective trial simulations when site recommendation models were utilized to select a portion of the country and site footprint,” the release stated. “Furthermore, Thermo Fisher expects to realize a 30% increase in the accuracy of forecasting trial milestones.”
Ico insights

INSIGHTS

SPONSORS' CONTENT
Untitleddesign2

The Importance of Real Estate Appraisals

Steve Mitchell - Cape Fear REALTORS®
Mcwhorter 0005

The Coastal Corridor is Helping Wilmington Startups With Connected Devices for Life Sciences Industry

Heather McWhorter - UNCW Center for Innovation and Entrepreneurship
Pfinder john zachary

What You Need to Know About SECURE 2.0 and Its Effect on Individual Retirement Accounts

John B Zachary - Pathfinder Wealth Consulting

Trending News

Conservation Group Signs $8M Deal To Buy The Point On Topsail Island

Audrey Elsberry - Mar 26, 2024

National Organization Bestows Top Award On Cape Fear Professional Women In Building

Staff Reports - Mar 26, 2024

Engineering Firm Hires Four Employees

Staff Reports - Mar 26, 2024

N.C. Ports Officials React To Baltimore Bridge Collapse

Audrey Elsberry - Mar 26, 2024

NCino's Fourth-quarter Earnings Signal Rebound From Liquidity Crisis

Audrey Elsberry - Mar 27, 2024

In The Current Issue

Park Progress

The planning for Pender Commerce Park began in the early 2000s when the county wanted to create an economic driver on its largely rural west...


INFO JUNKIE: Jack Fleming

Jack Fleming, owner of Socialry Marketing & Scourz and emcee for 1 Million Cups Wilmington, shares his media and tech picks....


MADE: Polyhose Inc.

Polyhose manufactures and fabricates hose protection, paint hose assemblies and rubber hydraulic assemblies from its Pender County facility....

Book On Business

The 2024 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

2023 Power Breakfast: Major Developments